169 reports of this reaction
2.3% of all BACITRACIN reports
#7 most reported adverse reaction
RASH is the #7 most commonly reported adverse reaction for BACITRACIN, manufactured by CVS Pharmacy. There are 169 FDA adverse event reports linking BACITRACIN to RASH. This represents approximately 2.3% of all 7,282 adverse event reports for this drug.
Patients taking BACITRACIN who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for BACITRACIN, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for BACITRACIN:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 169 FDA reports for BACITRACIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 2.3% of all adverse event reports for BACITRACIN, making it a notable side effect.
If you experience rash while taking BACITRACIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.